3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one vs Phenylbutazone
Mechanistic comparison of 3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one [Supplementary Concept] and Phenylbutazone based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
4
Shared Targets
18%
Jaccard Similarity
19%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Evidence Comparison
Target Overlap
3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one and Phenylbutazone share 4 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.182 means 18% of the combined target set is bound by both compounds. The IDF-weighted score of 0.188 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
Related Comparisons
Similar to 3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one
3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one vs Deslanoside4 targets3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one vs Thapsigargin4 targets3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one vs Proscillaridin3 targets3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one vs Homoharringtonine2 targets3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one vs Feprazone3 targets